Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros

Base de datos
Aspecto clínico
Intervalo de año
1.
Indian J Public Health ; 64(Supplement): S125-S127, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: covidwho-538987

RESUMEN

Hydroxychloroquine (HCQ), an antimalarial has been proposed as possible treatment for coronavirus disease-2019 (COVID-19). India has approved the use of HCQ for prophylaxis of asymptomatic health workers treating suspected or confirmed COVID-19 cases, and asymptomatic household contacts of confirmed patients. The U.S. Food and Drug Administration has issued Emergency Use Authorization for the use of HCQ to treat COVID-19 in adolescents and adults. In this review, we go over the available evidence for and against HCQ's use as prophylaxis or treatment for COVID-19, especially in the Indian context.


Asunto(s)
Antimaláricos/uso terapéutico , Infecciones por Coronavirus/tratamiento farmacológico , Hidroxicloroquina/uso terapéutico , Neumonía Viral/tratamiento farmacológico , Antibacterianos/uso terapéutico , Antimaláricos/administración & dosificación , Antimaláricos/efectos adversos , Azitromicina/uso terapéutico , Betacoronavirus , Quimioterapia Combinada , Humanos , Hidroxicloroquina/administración & dosificación , Hidroxicloroquina/efectos adversos , Pandemias
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA